About the Authors

Julien Pottecher

Roles Conceptualization, Investigation, Methodology, Writing – review & editing

Affiliation Strasbourg University Hospital, UR3072, FHU OMICARE, FMTS, Strasbourg, France

Francois Raffi

Roles Investigation, Writing – review & editing

Affiliation Nantes Université, CHU Nantes, INSERM, Department of Infectious Diseases, CIC 1413, Nantes, France

Martine Jandrot-Perrus

Roles Conceptualization, Writing – review & editing

Affiliations UMR_S1148 INSERM/Paris University, Paris, France, Acticor-Biotech, Paris, France

Sophie Binay

Roles Conceptualization, Methodology, Writing – review & editing

Affiliation Acticor-Biotech, Paris, France

Andrea Comenducci

Roles Methodology, Writing – review & editing

Affiliation Acticor-Biotech, Paris, France

Violaine Desort-Henin

Roles Methodology, Writing – review & editing

Affiliation Acticor-Biotech, Paris, France

Déborah François

Roles Investigation, Writing – review & editing

Affiliation Acticor-Biotech, Paris, France

Shahin Gharakhanian

Roles Writing – review & editing

Affiliations Acticor-Biotech, Paris, France, Shahin Gharakhanian MD Consulting LLC, Cambridge Innovation Center, Cambridge, MA, United States of America

Marilyn Labart

Roles Project administration, Writing – review & editing

Affiliation Acticor-Biotech, Paris, France

Adeline Meilhoc

Roles Project administration, Writing – review & editing

Affiliation Acticor-Biotech, Paris, France

Elie Toledano

Roles Data curation, Writing – original draft, Writing – review & editing

elie.toledano@acticor-biotech.com

Affiliation Acticor-Biotech, Paris, France

Yannick Pletan

Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing

Affiliation Acticor-Biotech, Paris, France

Gilles Avenard

Roles Conceptualization, Methodology, Validation, Writing – review & editing

‡ GA and VHS have contributed equally as Senior Authors on this work.

Affiliation Acticor-Biotech, Paris, France

Victor H. Sato

Roles Investigation, Methodology, Writing – review & editing

‡ GA and VHS have contributed equally as Senior Authors on this work.

Affiliation International Research Center, Hospital Alemão Oswaldo Cruz, Sao Paulo, Brazil

the GARDEN Investigators

GARDEN investigators list is provided in S1 Appendix.

Competing Interests

The authors are declaring the following links of interest. JP was a part of GARDEN study scientific committee and worked as a consultant for Acticor Biotech, he also has link with AOP Orphan, Baxter, Edwards Lifseciences, Masimo, LFB, RDS and Takeda outside the scope of this work. FR has consultancy agreement with Astra Zeneca, Gilead, MSD, Roche and ViiV Healthcare. MJP is a scientific co-founder, consultant and shareholder of Acticor-Biotech. GA is a co-founder, CEO and shareholder of Acticor-Biotech. SB is the CSO and GM of Acticor Biotech. YP is the CMO and GM of Acticor Biotech as a consultant and has stock interest in Acticor Biotech. SB, AC, DF, ML, AM and ET are employees and have stock interest in Acticor Biotech. SG, VDH and GA are consultant for Acticor Biotech. Other authors have no links to disclose. Acticor Biotech is a commercial company currently developing GARDEN study drug, glenzocimab, and holds several related patents/rights. GARDEN study was an industry sponsored trial, and Acticor Biotech was involved, or provided support, for study design, data collection and analysis, decision to publish, and preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.